Who are the key players in US Medical Plastics Market industry?

The top five players in the US Medical Plastics Market are BASF SE, Evonik Industries AG, Dow Inc., SABIC, and Celanese Corporation. These companies lead the market through continuous product innovation, strategic partnerships, and a robust distribution network, ensuring high-quality plastics meet strict medical industry standards.

What is the US Medical Plastics Market growth?

The US Medical Plastics Market has experienced strong growth, driven by the rising demand for single-use medical devices and equipment. In 2023, companies like Dow Inc. reported expansion in production capacity to meet healthcare sector needs, further accelerating market growth and innovation.

Which segment accounted for the largest US Medical Plastics Market share?

The medical disposables segment, including syringes, IV bags, and tubing, accounted for the largest share in the US Medical Plastics Market. Its dominance is attributed to increasing infection control measures and high consumption of single-use products in hospitals and healthcare centers.

What are the factors driving the US Medical Plastics Market?

Major factors include technological advancements in biodegradable plastics and a surge in healthcare spending. For example, SABIC has developed advanced polymer solutions for medical devices, supporting trends in minimally invasive procedures and driving market expansion.

Which type accounted for the largest US Medical Plastics Market share?

Polyvinyl chloride (PVC) accounted for the largest market share among plastic types used in the US medical plastics market. PVC remains widely favored for its flexibility, durability, and safety in producing tubing, blood bags, and containers used throughout the healthcare industry.

Home Chemical & Material

US Medical Plastics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: US Medical Plastics Market
Brand: Bussiness Insights

US Medical Plastics Market: by Type (Polyvinyl Chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), Polycarbonate (PC), Others), Application (Medical Devices, Disposables, Prosthetics, Implants, Drug Delivery, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Others), Technology (Injection Molding, Extrusion, Blow Molding, 3D Printing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 23-07-2025 | Format: PDF | Report ID:1460

US Medical Plastics Market Outlook and Forecast (2025-2035)

The US Medical Plastics Market is projected to experience sustainable growth from 2025 through 2035, fueled by technological advancements and increasing demand for lightweight, durable, and biocompatible materials. Medical plastics, such as PVC, PP, PE, PS, and PC, are extensively used for manufacturing medical devices, disposables, implants, and drug delivery systems due to their cost-effectiveness, versatility, and performance. As healthcare infrastructure expands and innovation accelerates in minimally invasive devices and personalized healthcare, medical plastics drive critical advancements. Strict safety standards and regulatory compliance also favor plastics that meet biocompatibility and sterility requirements. By 2025, the market’s revenue is set to surpass USD 12,300 Million, with notable growth in medical device and disposable applications.

Latest Market Dynamics

Key Drivers

Rising demand for single-use medical devices and disposables in response to infection control protocols has significantly boosted the use of plastics in the US healthcare sector. For example, in June 2024, Becton Dickinson (BD) announced expansions in their US manufacturing of disposable syringes to meet hospital demand.

The adoption of 3D printing in medical plastics manufacturing continues to rise, enabling cost-effective production of patient-specific devices. In August 2024, BASF SE partnered with Stratasys to supply advanced 3D-printable polymers for custom surgical tools.
Sustainable plastics innovation is gaining ground, with major suppliers launching recyclable and reduced-carbon-footprint materials. Eastman Chemical Company introduced a medical-grade copolyester produced with 30% certified recycled content in September 2024.

Expansion of telemedicine and home healthcare creates new opportunities for medical plastics in portable diagnostic and monitoring equipment. In June 2024, Philips invested in US facilities making home-care device components.
Rising investments in smart medical devices with integrated sensors and electronics require plastics that support miniaturization and electrical insulation, opening growth potential. In July 2024, Covestro AG launched an advanced polycarbonate series tailored for wearable diagnostics.

Meeting evolving regulatory standards, especially related to BPA and phthalates restrictions, remains a challenge for manufacturers. In June 2024, FDA updated guidance on medical plastic additives, compelling quick adaptation.
Supply chain disruptions and fluctuations in raw material prices, aggravated by global instability, strain production consistency and lead times. In July 2024, industry groups noted persistent volatility in resin availability.

Stringent environmental regulations and pressure for sustainability increase the cost of compliance and recycling for medical plastics producers. Recent legislation in California, introduced in August 2024, demands increased recycled content targets in medical packaging.
Growing market penetration of alternative materials, such as silicone or biodegradable composites, threatens the dominance of conventional medical plastics in certain high-value segments. For example, in June 2024, several major US hospitals piloted silicone-based catheters as replacements for PVC.

Polyvinyl Chloride (PVC) leads the medical plastics market in the US owing to its flexibility, cost-effectiveness, and suitability for a wide array of applications such as IV bags and tubing. Polypropylene (PP) and Polyethylene (PE) hold significant shares as well due to their chemical resistance and widespread use in packaging, containers, and laboratory equipment. Polystyrene (PS) and Polycarbonate (PC), known for clarity and impact resistance, are preferred for diagnostic and surgical devices. The dominance of these key polymers highlights ongoing manufacturing trends and regulatory acceptance, with emerging interest in specialty and bio-based plastics contributing to the 'Others' category.

Medical devices represent the largest application segment for medical plastics in the US, accounting for the major share of market demand in 2025 due to rapid innovation and an expanding product portfolio for diagnostics and therapeutics. Disposables, such as syringes, gloves, and tubing, follow closely as hospitals and clinics prioritize infection control. Drug delivery systems, prosthetics, and implants are also drawing increased investment as biocompatible plastics foster the development of customizable, patient-centric solutions. Other uses include laboratory ware and hospital furniture, pointing to the diversity of plastics’ utility in modern healthcare.

Market revenue for US medical plastics is estimated at USD 12,300 Million in 2025 and is projected to reach USD 22,150 Million by 2035, reflecting robust CAGR over the forecast period. This growth is driven by expanding healthcare activity, increased device adoption, and innovation in both materials and fabrication methods. The upward trajectory is expected to continue, reinforced by regulatory shifts favoring plastics and the introduction of next-generation smart devices.

The US medical plastics market is experiencing a healthy year-on-year growth trend driven by technology adoption and strong healthcare capital expenditure. After a surge in 2025 at 7.6%, the YOY growth rate is expected to average between 5.6% and 6.2% through 2030 as the market moderates at higher revenue base, with slight acceleration expected in the early 2030s due to breakthrough materials and increased digital healthcare penetration.

In 2025, the Northeast region accounts for the largest share of the US Medical Plastics Market, due to its concentration of major healthcare infrastructure, research activities, and industry clusters. The Midwest and West regions follow, driven by manufacturing activity and presence of leading medtech hubs. The South is an emerging market with significant growth potential, propelled by healthcare investment and favorable regulatory environments.

The major buyers in the US Medical Plastics Market are medical device manufacturers, holding the largest share, followed by hospital procurement groups and pharmaceutical companies. Custom contract manufacturers are also emerging as significant buyers as outsourcing trends accelerate. This reflects the sector's move toward higher value, precision components and total system integration in the supply chain.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	Revenue (USD Million)
Regions	Northeast, Midwest, West, South
Segments	By Type (Polyvinyl Chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), Polycarbonate (PC), Others), By Application (Medical Devices, Disposables, Prosthetics, Implants, Drug Delivery, Others), By Distribution Channels (Direct Sales, Distributors, Online, Retail, Wholesalers, Others), By Technology (Injection Molding, Extrusion, Blow Molding, 3D Printing, Compression Molding, Others), By Organization Size (Small, Medium, Large)
Players	BASF SE, SABIC, Evonik Industries AG, Arkema S.A., Celanese Corporation, Ensinger Inc., Röchling Group, DSM, Trinseo S.A., Lubrizol Corporation, RTP Company, Saint-Gobain, Celanese, Eastman Chemical Company, Covestro AG

June 12, 2024: BASF SE announced a partnership with Medtronic for sustainable supply of biocompatible plastics in the US.
July 18, 2024: Evonik Industries AG launched a new line of bioresorbable polymers for orthopedic implants and surgical tools.
August 5, 2024: Eastman Chemical Company introduced a copolyester with 30% certified recycled content for medical applications.
September 9, 2024: Covestro AG rolled out a new polycarbonate series for smart wearable medical devices in the US market.
July 25, 2024: Philips expanded its US manufacturing network for home healthcare diagnostic device plastics.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

US Medical Plastics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

US Medical Plastics Market Outlook and Forecast (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

US Medical Plastics Market Share by Type, 2025

US Medical Plastics Market Share by Application, 2025

US Medical Plastics Market Revenue (USD Million), 2020-2035

US Medical Plastics Market Year-on-Year Growth (%) (2020-2035)

US Medical Plastics Market Share by Region, 2025

US Medical Plastics Market Players Share, 2025

US Medical Plastics Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently asked questions